PROTAGONIST THERAPEUTICS
LIVE

Serial Number

88450820

Owner

Protagonist Therapeutics, Inc.

Attorney

Melissa A. Nowak

First Use Date

May 10, 2016

Filing Date

May 29, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PROTAGONIST THERAPEUTICS Trademark

Serial Number: 88450820 • Registration: 6142951

PROTAGONIST THERAPEUTICS is a trademark filed by Protagonist Therapeutics, Inc. on May 29, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Protagonist Therapeutics, Inc. (9 trademarks)

Suite 140
Newark, CA 94560

Entity Type: 03

Trademark Details

Filing Date

May 29, 2019

Registration Date

September 1, 2020

First Use Anywhere

May 10, 2016

First Use in Commerce

May 10, 2016

Published for Opposition

December 17, 2019

Goods & Services

SCIENTIFIC RESEARCH, PHARMACEUTICAL RESEARCH, MEDICAL RESEARCH; [ TECHNICAL AND SCIENTIFIC CONSULTATION AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS, IN THE FIELD OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES; ] RESEARCH AND DEVELOPMENT OF NEW PRODUCTS PERTAINING TO THE TREATMENT OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND TO PHARMACEUTICALS; PROVIDING ON-LINE INFORMATION FOR MEDICAL RESEARCH PURPOSES, IN THE FIELDS OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, TREATMENTS FOR IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND PHARMACEUTICALS

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 12, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 12, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 12, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 17, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 1, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 28, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 28, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 28, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 28, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 28, 2023 COAR
CORRECTION UNDER SECTION 7 - PROCESSED
Sep 17, 2021 COC.
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sep 16, 2021 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
Jul 7, 2021 PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
Jul 6, 2021 PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
Jul 6, 2021 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 6, 2021 APRE
SEC 7 REQUEST FILED
Mar 11, 2021 AMD7
TEAS SECTION 7 REQUEST RECEIVED
Mar 11, 2021 ES7R
REGISTERED-PRINCIPAL REGISTER
Sep 1, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 25, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 24, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 23, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 23, 2020 AITU
USE AMENDMENT FILED
Jul 2, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 2, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 11, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2019 NONP
ASSIGNED TO LIE
Nov 12, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 5, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 5, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 21, 2019 GPRN
PRIORITY ACTION E-MAILED
Aug 21, 2019 GPRA
PRIORITY ACTION WRITTEN
Aug 21, 2019 CPRA
ASSIGNED TO EXAMINER
Aug 19, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 14, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 13, 2019 NWOS
NEW APPLICATION ENTERED
Jun 1, 2019 NWAP